Meet Dr. Cameron Clokie the CEO of Canada’s Induce Biologics Inc.

Manipulating bones to grow especially in adults seems like an impossibility, but regenerative medicine is capable of it. The field of medicine which is somewhat controversial is improving every single day, and it could soon be appealing to people who currently hold a different view courtesy of their religious beliefs. Learn more about Cameron Clokie: http://www.ideacity.ca/speaker/cameron-clokie/

For example, one Canadian doctor—Cameron Clokie—is at an advanced stage of scientific research aimed at the sourcing of bone morphogenetic protein (BMP) from an alternative source than cadavers. The protein is at the heart of regenerative medicine. Dr. Clokie’s plans involve nurturing a human gene that produces BMP inside a goat’s body.

As a result, goats will dispense the protein in large quantities through their milk. If Dr. Clokie’s plans materialize, he will be one step ahead of making regenerative medicine widely acceptable.

Who is Dr. Cameron Clokie? He is the go-to professional regarding regenerative medicine. Part of his 30-year career in either in academic dentistry or clinical practice somehow focused on regenerative medicine. Dr. Clokie has authored many peer-reviewed papers touching on regenerative medicine. Read more: Bros Don’t Let Bros Have Bad Breath: Toronto Oral Surgeon Cameron Clokie Helps You Make a Good First Impression

He is frequently invited to conferences both in Canada and abroad to talk about what he is well-versed in, regenerative medicine. Before his retirement earlier in the year, he was a professor at the University of Toronto. He was also the in charge of Oral and Maxillofacial Surgery at the same institution.

Dr. Clokie’s interest in regenerative medicine extends past clinical practice and academics; he is an entrepreneur in the field of medicine.

Besides being a board member or scientific advisor to many companies interested in scientific research, Dr. Clokie has partnered with companies that are willing to commercialize some of his research work. Dr. Clokie’s over 25 patents in the U.S and other parts of the world demonstrates his interest to uncover new helpful findings.

Presently, Dr. Clokie is the president of Induce Biologics Inc. The Canadian based firm has carved a niche for itself as the world’s leading center where innovative solutions for musculoskeletal reconstruction are abundant.

Induce Biologics comprises professionals who match up to Dr. Clokie’s expertise in regenerative medicine. The firm is working round the clock to make regenerative medicine more efficient and acceptable.

Madison Street Capital Announced as Finalist for the 15th Annual M&A Advisor Awards

The M&A Advisor has announced that the Madison Street Capital financial banking institution is among the finals at the 15th Annual M&A Advisor Awards. The awards, respected widely as a pinnacle of achievement in the financial world, recognize their deal-making excellence. They are recognized as leaders in financing and restructuring. These awards celebrate the achievements and contributions of leading professionals and firms.

Madison Street Capital is one of the nominees for the Industrials and International Deal of the year (Under $100 M) and the Boutique Investment Banking Firm of the year. These awards recognize Madison Street Capital’s role in the Acuna & Asociados S.A. acquisition by Dowco. The managing director of Madison Street Capita, Karl D’Cunha, has led the transaction.

Charles Botchway, the CEO and founder of Madison Street Capital, says that they are extremely pleased with their ability to assist their clients in their Acuna & Asociados S.A. acquisition. They are honored and thrilled to run for the Boutique Investment Banking Firm of the year. For continued growth and success, he says that their deal-makers work tirelessly to connect their clients with the emerging and growing businesses to suit their diverse needs.

The acquisition of Acuna Asociados S.A. by Dowco Company was a cross-border transaction that flexed the muscles of Madison Street Capital. For the sake of that achievement, it feels great. The winners of these awards will be announced at the Annual M&A Acquisition Gala Advisor Awards in New York Athletic Club.

Madison Street Capital is one of the biggest investment banks in the United States. It is committed to leadership, integrity, service, and excellence in delivering mergers and acquisition expertise, financial advisory services, valuation services to privately and publicly-held companies. These services position their clients to take advantage of the dynamic global market. The customer’s objectives and goals become Madison Street Capital’s in undertaking their projects. These services range from successful capital raises and financial advisory to M&A acquisitions to ownership transfer. The company views the emerging trends in the market as the components driving the world growth of clients. Madison Street Capital continues to focus on significant market assets. The firm continues to earn client’s trust in the world through their unwavering dedication to professional standards.

For over 15 years, the company has established itself as the focal point regarding the global network of mergers and acquisition. They are also leaders in financial professions and Turnaround. While they remain privileged in presenting, they also recognize connection facilitation and achievements between the top performers in this industry. They know the companies that take the lead in their services. http://www.benzinga.com/pressreleases/16/08/r8401008/madison-street-capital-announced-as-finalist-for-the-15th-annual-m-a-ad